Join the BioForum - Advancing Non-Animal Models in Biomedical Research
27 February 2024
BioMelbourne Network is hosting a discussion about the transformative potential of non-animal models to study complex biological processes, advance science and generate over $1.5 billion in revenue and over 5,000 jobs in Australia by 2024.
Learn how human-derived models such as 3D-cell cultures, organoids and organ-on-chip technologies and microfluidic platforms offer valuable alternatives in research, drug discovery programs and preclinical trials, where traditionally animals are used. And the implications of this advancement for both our health tech sector and local economy.
Be informed about:
- Non-animal models – the what, why and who
- Economic opportunities – investment incenti ves, global competitiveness and job creation
- Challenges and solutions – non-animal model limitations and improving reliability
- Support – partnerships, regulation and infrastructure
- Ethics – aligning research with evolving societal values.
The session will be facilitated by Christos Papadimitriou, CEO and Managing Director, Tessara Therapeutics Pty Ltd with the follow guest speakers:
- Professor Carl Kirkpatrick, Professor of Pharmacy Practice, Centre for Medicine Use and Safety, Monash University
- Laura Thomas, Strategy Manager, CSIRO
- Dr Ella Robinson, Senior Impact and Ethics Analyst, Australian Ethical
This event is intended for:
- Professionals seeking to improve knowledge and foster connections
- Scientists and clinicians engaging in research, disease modelling, drug discovery, preclinical and clinical trials
- Biobank representatives, grant funding bodies, regulators and policy makers.
The hybrid event will be held on Thursday 29 February 2024
Time (AEDT):3:45 pm - 5:45pm for presentation and QA. Networking to follow
Venue/Online: ACMI, Swinburne Studio, Federation Square, Melbourne 3000